Home / Etoricoxib / Ireland
IE ATC M01AH05 · updated 2 Nov 2026
Etoricoxib shortage in Ireland
Is there an Etoricoxib shortage in Ireland?
Yes. As of 2 Nov 2026, 6 Etoricoxib products are reported short in Ireland, the first since 10 Dec 2025. The company estimate for the return is 11 Nov 2026 (latest 28 Feb 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Belgium, Norway, Sweden. All countries.
Affected products in Ireland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IE | Etoricoxib Teva 30 mg film-coated tablets | Teva B.V. | 10 Dec 2025 | 28 Feb 2027 | Manufacturing problem Manufacturing delay |
| IE | Etoricoxib 30 mg film-coated tablets | Viatris Limited | 13 Jul 2026 | 4 Jan 2027 | Manufacturing problem Manufacturing delay |
| IE | Etoricoxib 90 mg film-coated tablets | Viatris Limited | 31 Aug 2026 | not given | Manufacturing problem Manufacturing delay |
| IE | Etoricoxib Teva 120 mg film-coated tablets | Teva B.V. | 4 Oct 2026 | 11 Nov 2026 | Manufacturing problem Manufacturing delay |
| IE | Etoricoxib Krka 30 mg film-coated tablets | KRKA, d.d., Novo mesto | 8 Oct 2026 | 15 Nov 2026 | Increased demand Unexpected increased demand |
| IE | Arcoxia 30 mg film-coated tablets | NV Organon | 29 Oct 2026 | 14 Dec 2026 | Manufacturing problem Manufacturing delay |
Source
HPRA (Health Products Regulatory Authority). Official list. Shortages notified to the HPRA by marketing-authorisation holders; one row per pack.